Patient Demographic and Baseline Characteristics
TIA, ischemic stroke
TIA, ISCHEMIC STROKE
A total of 6412 patients (median age, 64.8 years [IQR, 57.0-71.4 years]; 4242 men [66.2%]) with ischemic stroke or TIA were enrolled from 202 clinical sites in the CHANCE-2 trials, with 3205 randomly assigned to the ticagrelor-aspirin group and 3207 to the clopidogrel-aspirin group.